June 16, 2022
According to the business intelligence report titled ‘China Non-Invasive Prenatal Testing Market Size, Trends, Share, Growth, Opportunity, and Forecast 2022 – 2028’, available with MarketStudyReport, China non-invasive prenatal testing market is anticipated to register a healthy CAGR of 6.4% over the next seven years and amass a sizable valuation of USD 825 million by the year 2028.
Rising prevalence of pregnancy related complications and miscarriages, along with growing risk of chromosomal defects with rising maternal age are driving China non-invasive prenatal testing market growth.
Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/4617179/
Moreover, increasing awareness regarding prenatal testing, notable technological advancements in the field, and favorable reimbursement policies for low-risk pregnancies are likely to unearth new opportunities for market expansion in the forthcoming years.
Besides, increasing focus on improving healthcare infrastructure of the nation will enhance revenue generation in the ensuing years.
However, challenges in the form of lack of skilled healthcare professionals and the expensive nature of prenatal testing may hinder the growth trajectory of China non-invasive prenatal testing marketplace during the assessment period.
While the analysis about growth drivers and challenges will enable the stakeholders in understanding the industry dynamics, information about present medical reimbursement scenario will help in making the decisions about the future. Also, data related to number of NIPT done in China in the past years is given.
Speaking of the competitive landscape, BGI Diagnostics Co. Ltd. (BGI Group), Berry Genomics Co. Ltd., and Basetra are the leading industry players that are influencing China non-invasive prenatal testing market trends. These companies are thoroughly analyzed in terms of their current portfolio, status of business operations, recent developments, and new product launches for readers to gain a thorough understanding and reach their own conclusions regarding the profitability of the organizations.